Home/ Supplements/ Vitamin K/ Vitamin K-2

Vitamin K-2

product on market Softgel Capsule NewtonEverett Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K-2 is supported by strong evidence for its role in regulating calcium metabolism and supporting bone and cardiovascular health. Research indicates it helps direct calcium into bones and away from arterial walls. The ingredient profile is associated with a high safety rating.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vitamin K-2
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
120
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

50 mcg (63% DV)
Within RDA (0.4× RDA) 275 studies (A:9, B:175)

Other Ingredients

Sunflower seed Oil Gelatin Vegetable Glycerin Contains Less Than 2% of
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Directions: For adults, take one (1) softgel daily, preferably with a meal.

Warnings & Precautions

Warning: If you are pregnant, nursing or taking any medications, consult your doctor before use.

Discontinue use and consult your doctor if any adverse reactions occur

KEEP OUT OF REACH OF CHILDREN.

Not suitable for vegetarians.

Contains soy ingredients.

Formulation Notes

No artificial flavor or sweetener, preservatives, sugar, starch, milk, lactose, gluten, wheat, yeast or shellfish. Sodium free.

Contains soy ingredients.

Additional Information

Pure - Potent - Bioavailable We are driven to deliver highly potent, ultra-pure nutritional products with uncompromised quality. Our premium-grade liquid softgels are designed to provide an ideal delivery vehicle for maximum absorption and enhanced bioavailability.

Store at room temperature.

newtoneverett(R)

Made in USA

Metadata

Product Details

UPC / SKU6 89076 03145 5
DSLD Entry Date2014-06-25
Product TypeVitamin
FormSoftgel Capsule
DSLD ID34784
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.